ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

What Does This Regulatory News Mean for Bristol Myers Squibb's Shareholders?
In late November, the U.S. Food and Drug Administration (FDA) announced that it accepted Bristol Myers Squibb's (NYSE: BMY) New Drug Application for deucravacitinib as a treatment for patients with moderate-to-severe psoriasis.
Announcement as on 03 January 2022

Bristol Myers Squibb raises quarterly dividend and adds billion to share buyback program
Bristol Myers Squibb Co. shares rose 2% in premarket trade Monday, after the company announced a 10.2% increase in its quarterly dividend and added billion to its share buyback authorization. The new dividend of 54 cents a share will be payable Feb. 1
Announcement as on 13 December 2021

Is A Rise Imminent For Bristol Myers Squibb Stock?
The stock price of Bristol Myers Squibb (NYSE:BMY) has seen a decline of 8% over the last month, while it is down 6% over the last week. This can partly be attributed to a larger decline in the broader markets with the S&P 500 also falling over 3% last wee
Announcement as on 05 December 2021

Is A Rise Imminent For Bristol Myers Squibb Stock?
The stock price of Bristol Myers Squibb (NYSE:BMY) has seen a decline of 8% over the last month, while it is down 6% over the last week. This can partly be attributed to a larger decline in the broader markets with the S&P 500 also falling over 3% last wee
Announcement as on 05 December 2021

Compugen's stock jumps after Bristol Myers Squibb completes million investment into the company
Shares of Compugen Ltd. gained 13.4% in premarket trading on Thursday after Bristol Myers Squibb Co. completed a million investment in the company. Compugen's stock is down 48.1% so far this year, while the broader S&P 500 is up 25.2%. Market Pulse
Announcement as on 11 November 2021

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 63.47
  • 12Day Average: 64.7
  • 20Day Average: 65.67
  • 50Day Average: 64.1
  • 100Day Average: 60.47
  • 150Day Average: 60.17
  • 200Day Average: 58.96

BMY Indicators & signals

Indicator MACD (12,26,9)

64.3, 64.65, 0.19
Indicator MACD is in negative zone

Indicator ADX (14)

7.94, 20.28, 23.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 63.06 62.19 to 63.07 0.35% 4.87 times
17 Thu Sep 2026 62.84 62.52 to 64.35 -1.19% 1.61 times
16 Wed Sep 2026 63.60 63.22 to 64.39 -0.2% 1.25 times
15 Tue Sep 2026 63.73 63.15 to 64.13 -0.58% 1.32 times
14 Mon Sep 2026 64.10 63.83 to 65.29 0.72% 0.44 times
11 Fri Sep 2026 63.64 63.27 to 64.20 -0.17% 0.93 times
10 Thu Sep 2026 63.75 63.73 to 64.92 -1.02% 0.86 times
09 Wed Sep 2026 64.41 64.26 to 65.05 -0.43% 0.87 times
08 Tue Sep 2026 64.69 64.40 to 65.89 -3.19% 1.26 times
04 Fri Sep 2026 66.82 66.58 to 67.72 -1.87% 0.64 times
03 Thu Sep 2026 68.09 66.62 to 68.24 0.64% 0.82 times
02 Wed Sep 2026 67.66 66.64 to 67.73 1.11% 0.45 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

 

Back to top